Baylor College of Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Baylor College of Medicine (BCM) is a health science university that offers educational services. The university provides knowledge and applies science and discoveries to further education, healthcare and community services. It provides healthcare services through the integration of research, patient care, education and community services, among others. BCM offers training to medical, graduate, nurse anesthesia, physician assistant students, residents and post doctoral fellows. The university offers degree programs in various fields including biochemistry and molecular biology; cell and molecular biology; clinical scientist training program; developmental biology; molecular and cellular biology; molecular and human genetics; molecular physiology and biophysics; molecular virology and microbiology; neuroscience; pathology and immunology, among others. It provides patient services including appointment requests, online payments and billing, privacy notices, and temporary housing information. BCM is headquartered in Houston, Texas, the US.

Baylor College of Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 6
List of Figures 6
Baylor College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Baylor College of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Baylor College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Baylor College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Baylor College of Medicine, Medical Devices Deals, 2012 to YTD 2018 11
Baylor College of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Baylor College of Medicine, Pharmaceuticals & Healthcare, Deal Details 14
Partnerships 14
VistaGen Therapeutics and Baylor College of Medicine Enter into Agreement 14
Context Therapeutics Enters into Research Collaborations for Apristor 15
NeuroRx Enters into Agreement with US Department of Veterans and Baylor College of Medicine 17
Millipore Enter into Partnership with Baylor College of Medicine and Texas Childrens Hospital 18
Tessa Therapeutics Enters into Co-Development Agreement with Baylor Medical College 19
Baylor College of Medicine Enters into Research Agreement with Baylor Scott & White Health 20
NanoViricides Enters into Agreement with Baylor College of Medicine 21
UCB Enters into Research Agreement with Baylor College of Medicine 22
Baylor College of Medicine Enters into Partnership with National Urea Cycle Disorders Foundation 23
Baylor College to Form Joint Venture with Miraca 24
Baylor College of Medicine Enters Into Agreement With DNAnexus 25
Gradalis Enters Into Co-Development Agreement With Baylor College of Medicine 26
Licensing Agreements 27
Flexion Therapeutics to Acquire Rights to GQ-203 27
ViraCyte Enters into Licensing Agreement with Baylor College of Medicine 28
Bellicum Pharmaceuticals Enters Into Licensing Agreement with Baylor College of Medicine 29
Cell Medica Extends Licensing Agreement with Baylor College of Medicine 30
Bellicum Pharma Enters into Licensing Agreements with Baylor College of Medicine 32
Brighton Biotech Enters into Licensing Agreement with Baylor College of Medicine 33
Tessa Therapeutics Enters into Licensing Agreement with Baylor College of Medicine 34
Acer Therapeutics Enters into Licensing Agreement with Baylor College of Medicine 35
Bellicum Pharma Enters into Licensing Agreement with Baylor College of Medicine 36
Shenzhen TianDeMedical Investment Enters into Licensing Agreement with Baylor College of Medicine 37
Baylor College of Medicine Enters into Licensing Agreement with Vax-Immune 38
Celgene Enters into Licensing Agreement with Baylor College of Medicine 39
Baylor College of Medicine Enters into Licensing Agreement with BioSeed Ventures 40
TyRx Pharma Enters Into Licensing Agreement with Baylor College of Medicine 41
ATCC Enters into Licensing Agreement with Baylor College of Medicine 42
StemMed Enters into Licensing Agreement with Baylor College of Medicine 43
Baylor College of Medicine - Key Competitors 44
Baylor College of Medicine - Key Employees 45
Baylor College of Medicine - Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Joint Venture 46
Recent Developments 47
Government and Public Interest 47
Nov 26, 2018: DPYSL3 an outlier gene in triple-negative breast cancer 47
Nov 20, 2018: Researchers receive New Therapies Challenge grant 49
Nov 16, 2018: Repurposing FDA-approved drugs to fight breast cancer 51
Nov 12, 2018: Novel strategy may reduce breast cancer bone metastasis 52
Nov 02, 2018: Gene PPM1D gives stem cells a winning boost after chemotherapy 54
Oct 25, 2018: Estrogen receptor can affect resistance to endocrine therapy and metastasis in breast cancer 55
Oct 18, 2018: $5 million grant to expand blood cancer therapy options 56
Oct 17, 2018: New therapies to treat naturally occurring eye diseases focus of $6 million grant from the National Eye Institute 57
Oct 01, 2018: Hormone therapy trial leads to hope in breast cancer fight 58
Sep 28, 2018: Researchers find missplicing Scn5a alters cardiac function 59
Sep 18, 2018: Grant supports identifying leukemia, Down syndrome link 60
Sep 06, 2018: $2 million grant to fund pregnancy resuscitation program 61
Aug 30, 2018: New histiocytotic disorder insights may improve therapies 62
Aug 27, 2018: Baylor awarded CPRIT Grants for research, recruitment 63
Aug 24, 2018: CPRIT Surpasses $2 Billion Milestone with 64 New Grants 64
Jul 27, 2018: Looking at DNA repair defects may help identify elusive form of breast cancer 70
Jul 25, 2018: The dark side of antibiotic ciprofloxacin 71
Jul 18, 2018: St. Baldricks foundation announces $19.1 million in grants to fund lifesaving childhood cancer research 73
Jul 16, 2018: Space Health Institute awards grants to three companies 74
Jul 02, 2018: Study: Zika could cause more miscarriages than we realize 75
Jun 26, 2018: Engineered T cells made to recognize tumor-specific patterns 76
Jun 20, 2018: Scientists develop new approach to understand Huntingtons 77
May 25, 2018: DNA repair defect may drive some cancer treatment resistance 79
May 22, 2018: Bayer Awards Grants to Patient Caregiver and Hemophilia Researchers 80
May 21, 2018: New data changes the way scientists explain how cancer tumors develop 81
May 21, 2018: New therapy for pediatric brain tumors could reduce long-term cognitive issues 82
May 10, 2018: $5 million supports innovative breast cancer trial 83
May 02, 2018: NIH renews grant to advance digestive disease research 84
Apr 16, 2018: Study finds elimination of p63 gene could convert scar tissue into muscle tissue in the heart 85
Mar 26, 2018: New promise found in treating triple negative breast cancer 86
Mar 12, 2018: Biomarkers help predict cardiovascular disease in older adults 87
Mar 01, 2018: Repairing rotavirus-damaged intestinal cells 89
Feb 26, 2018: Baylor College of Medicine awarded $3 million from CPRIT 90
Feb 26, 2018: Scorpion venom component may treat rheumatoid arthritis 91
Feb 22, 2018: Defects on regulators of disease-causing proteins can cause neurological disease 92
Feb 21, 2018: New treatment offers pain relief without surgery 93
Feb 15, 2018: Baylor team shortlisted for Cancer Research UK grants 94
Feb 12, 2018: Classification can lead to new ways to diagnose, treat cancer 95
Feb 09, 2018: BRAIN grant funds study of neurocircuitry of depression 96
Feb 02, 2018: Gene playing major role in neurological condition found 97
Jan 22, 2018: Immunotherapy treatment gives lung cancer patient second chance 98
Jan 11, 2018: Researchers identify new potential drug target for Huntingtons disease 99
Jan 05, 2018: Knights Templar Eye Foundation gives $2M for endowed chair 101
Jan 04, 2018: Research reveals path to ependymoma chemotherapy 102
Jan 03, 2018: Primate genomics study reveals clues into AIDS resistance 103
Dec 21, 2017: Baylor College of Medicine: G-quadruplex regulates breast cancer-associated gene 104
Nov 28, 2017: Baylor only Texas site awarded NCI grant to help end smoking 105
Nov 22, 2017: SONG Initiative gives kidney disease patients a voice in their treatment 106
Nov 13, 2017: Defects in cells waste disposal system linked to Parkinsons 107
Oct 31, 2017: Chromosome organization emerges from 1-D patterns 108
Oct 30, 2017: Antibody treatment for HER2-positive breast cancer gives patient new outlook 110
Oct 24, 2017: BRAIN Initiative Grant Aims to Identify Brains Building Blocks 111
Oct 16, 2017: Mechanism explains how seizures may lead to memory loss 112
Oct 06, 2017: Study reveals benefit of exome sequencing for infants in ICU 114
Oct 05, 2017: Better understanding of bladder cancer subtypes might lead to improved treatments 115
Sep 28, 2017: Breakdown of Brain cells Collaboration Linked to Alzheimers 116
Sep 26, 2017: Study outlines precancerous treatment of anal lesions 118
Sep 26, 2017: NCI renews lymphoma immunotherapy research grant 119
Sep 21, 2017: Grant funds chemotherapy-free breast cancer therapy research 120
Sep 20, 2017: Space research institute awards 10 research grants 121
Aug 24, 2017: Research reveals how estrogen regulates gene expression 123
Aug 23, 2017: Test reveals possible treatments for disorders involving MeCP2 124
Aug 18, 2017: CPRIT awards $13M for prevention, research, recruitment 126
Aug 07, 2017: Clinical trial shows ready-to-use cells are safe and effective to treat viral infections 128
Aug 02, 2017: National Science Foundation grant to fund new brain research 130
Jul 18, 2017: How CD44s gives brain cancer survival advantage 132
Jul 13, 2017: Researchers identify potentially safer substitutes for BPA 133
Jun 07, 2017: Nations Largest Suicide Prevention Organization Awards $1Million Research Grant to Houston Physician 135
Jun 05, 2017: Chikungunya vaccine trial underway at Baylor 136
Apr 21, 2017: New bone-in technique tests therapies for breast cancer metastasis 137
Mar 23, 2017: Cryo-electron microscopy achieves unprecedented resolution using new computational methods 138
Jan 03, 2017: Bipolar disorder and epilepsy linked to turning down an inhibitory switch in brain circuits 139
Product News 141
Jun 15, 2018: First-in-human clinical trial aims to treat neuroblastoma 141
Jun 13, 2018: Scientists Detect New Ovarian Cancer Target, Find Existing Drug To Potentially Treat It 142
May 07, 2018: Baylor to participate in NIH trial for universal flu vaccine 144
01/25/2018: Gene-modified, virus-specific T cell therapy shows promise in treating lymphoma, with little toxicity 145
Clinical Trials 146
Sep 20, 2018: First neuroblastoma patient successfully dosed with innovative CAR therapy utilizing natural killer T cells (CAR-NKT) 146
Dec 04, 2017: Alexs Lemonade Stand funds Phase 1 neuroblastoma trial 148
Other Significant Developments 149
Nov 20, 2018: FROM THE LABS: A potential new purpose for an old drug 149
Oct 03, 2018: Baylor, Rebiotix find patient microbiome signatures that differentiate disease states 151
Jul 19, 2018: Analytical tool predicts disease causing genes 152
Jun 08, 2018: Gene editing just got easier 154
May 04, 2018: Xia-Gibbs Syndrome study led to new patient registry 156
Appendix 157
Methodology 157
About GlobalData 157
Contact Us 157
Disclaimer 157

List Of Tables


Baylor College of Medicine, Pharmaceuticals & Healthcare, Key Facts 2
Baylor College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Baylor College of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Baylor College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Baylor College of Medicine, Deals By Therapy Area, 2012 to YTD 2018 10
Baylor College of Medicine, Medical Devices Deals, 2012 to YTD 2018 11
Baylor College of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
VistaGen Therapeutics and Baylor College of Medicine Enter into Agreement 14
Context Therapeutics Enters into Research Collaborations for Apristor 15
NeuroRx Enters into Agreement with US Department of Veterans and Baylor College of Medicine 17
Millipore Enter into Partnership with Baylor College of Medicine and Texas Childrens Hospital 18
Tessa Therapeutics Enters into Co-Development Agreement with Baylor Medical College 19
Baylor College of Medicine Enters into Research Agreement with Baylor Scott & White Health 20
NanoViricides Enters into Agreement with Baylor College of Medicine 21
UCB Enters into Research Agreement with Baylor College of Medicine 22
Baylor College of Medicine Enters into Partnership with National Urea Cycle Disorders Foundation 23
Baylor College to Form Joint Venture with Miraca 24
Baylor College of Medicine Enters Into Agreement With DNAnexus 25
Gradalis Enters Into Co-Development Agreement With Baylor College of Medicine 26
Flexion Therapeutics to Acquire Rights to GQ-203 27
ViraCyte Enters into Licensing Agreement with Baylor College of Medicine 28
Bellicum Pharmaceuticals Enters Into Licensing Agreement with Baylor College of Medicine 29
Cell Medica Extends Licensing Agreement with Baylor College of Medicine 30
Bellicum Pharma Enters into Licensing Agreements with Baylor College of Medicine 32
Brighton Biotech Enters into Licensing Agreement with Baylor College of Medicine 33
Tessa Therapeutics Enters into Licensing Agreement with Baylor College of Medicine 34
Acer Therapeutics Enters into Licensing Agreement with Baylor College of Medicine 35
Bellicum Pharma Enters into Licensing Agreement with Baylor College of Medicine 36
Shenzhen TianDeMedical Investment Enters into Licensing Agreement with Baylor College of Medicine 37
Baylor College of Medicine Enters into Licensing Agreement with Vax-Immune 38
Celgene Enters into Licensing Agreement with Baylor College of Medicine 39
Baylor College of Medicine Enters into Licensing Agreement with BioSeed Ventures 40
TyRx Pharma Enters Into Licensing Agreement with Baylor College of Medicine 41
ATCC Enters into Licensing Agreement with Baylor College of Medicine 42
StemMed Enters into Licensing Agreement with Baylor College of Medicine 43
Baylor College of Medicine, Key Competitors 44
Baylor College of Medicine, Key Employees 45
Baylor College of Medicine, Subsidiaries 46
Baylor College of Medicine, Joint Venture 46

List Of Figures


Baylor College of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Baylor College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Baylor College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Baylor College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Baylor College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Baylor College of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Baylor College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Baylor College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Baylor College of Medicine, Medical Devices Deals, 2012 to YTD 2018 11

Baylor Scott and White Health - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Baylor Scott & White Health (Baylor Scott & White) is a not-for-profit healthcare service provider that offers medical care services. The organization offers medical education, medical services and conducts medical

USD 250 View Report

Baylor College of Medicine - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Baylor College of Medicine - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Baylor College of Medicine Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes

USD 350 View Report

Baylor College of Medicine - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Baylor College of Medicine - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Baylor College of Medicine Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes

USD 350 View Report

Baylor College of Medicine - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Baylor College of Medicine - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportMarketlines Baylor College of Medicine Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes

USD 350 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available